Sarcomatrix Therapeutics Accredited Investor Round Scheduled to Close October 31

RENO, Nev., October 22, 2026 (KOREWIRE) ... Sarcomatrix Therapeutics Corp., a Delaware corporation based in Reno, Nevada, today reminded prospective investors that its accredited investor round, conducted under Regulation D, Rule 506(c), is scheduled to close on October 31, 2026, the closing date the company announced on October 1, 2026. The round runs on the KoreInside platform, with KoreTransfer USA LLC acting as transfer agent. The closing date remains subject to earlier closing if the round...